The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Altered Responsiveness to Cocaine and Increased Immobility in the Forced Swim Test Associated with Elevated cAMP Response Element-Binding Protein Expression in Nucleus Accumbens
Open accessAbstract
Drugs of abuse regulate the transcription factor cAMP response element-binding protein (CREB) in striatal regions, including the nucleus accumbens (NAc). To explore how regulation of CREB in the NAc affects behavior, we used herpes simplex virus (HSV) vectors to elevate CREB expression in this region or to overexpress a dominant-negative mutant CREB (mCREB) that blocks CREB function. Rats treated with HSV-mCREB in place conditioning studies spent more time in environments associated with cocaine, indicating increased cocaine reward. Conversely, rats treated with HSV-CREB spent less time in cocaine-associated environments, indicating increased cocaine aversion. Studies in which drug-environment pairings were varied to coincide with either the early or late effects of cocaine suggest that CREB-associated place aversions reflect increased cocaine withdrawal. Because cocaine withdrawal can be accompanied by symptoms of depression, we examined how altered CREB function in the NAc affects behavior in the forced swim test (FST). Elevated CREB expression increased immobility in the FST, an effect that is opposite to that caused by standard antidepressants and is consistent with a link between CREB and dysphoria. Conversely, overexpression of mCREB decreased immobility, an effect similar to that caused by antidepressants. Moreover, the kappa opioid receptor antagonist nor-Binaltorphimine decreased immobility in HSV-CREB- and HSV-mCREB-treated rats, suggesting that CREB-mediated induction of dynorphin (an endogenous kappa receptor ligand) contributes to immobility behavior in the FST. Exposure to the FST itself dramatically increased CREB function in the NAc. These findings raise the possibility that CREB-mediated transcription within the NAc regulates dysphoric states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The NAC shell is activated during stress in rats and mice, and this same activation in mice is blocked by CRF-R1 antagonist (Pliakas et al 2001; Kreibich et al 2009).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Pliakas et al 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., WATSON, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,501
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133
Gonzalez, G. A., & Montminy, M. (1989) · Cell · doi:10.1016/0092-8674(89)90013-5 · Cited by 2,464
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,133
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Molecular basis of long-term plasticity underlying addiction
Nestler, E. J. (2001) · Nature reviews. Neuroscience · doi:10.1038/35053570 · Cited by 1,893
Self-citationAn opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
Detke, M. J., Rickels, M. R., & Lucki, I. (1995) · Psychopharmacology · doi:10.1007/bf02245592 · Cited by 1,466
Research works printed but not linked: 1
- Carr GD, Fibiger HC, Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: The neuropharmacological basis of reward (Liebman JM, Cooper SJ, eds), pp 264 -319. Oxford: Clarendon.
Cited by
Sorted by citations
Items 101–200 of 509
Wallace, T. L., Stellitano, K. E., Neve, R. L., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.010 · Cited by 133
Self-citationLarson, E. B., Graham, D. L., Arzaga, R. R., Buzin, N., Webb, J., Green, T. A., Bass, C. E., Neve, R. L., Terwilliger, E. F., Nestler, E. J., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3070-11.2011 · Cited by 127
Self-citationBerrocoso, E., Sánchez‐Blázquez, P., Garzón, J., & Micó, J. A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168100 · Cited by 131
Molecular and genetic substrates linking stress and addiction
Briand, L. A., & Blendy, J. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.002 · Cited by 125
Genetic Approaches to Investigate the Role of CREB in Neuronal Plasticity and Memory
Barco, Á., & Marie, H. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8209-x · Cited by 131
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in Wistar Kyoto Rats
Carr, G. V., Bangasser, D. A., Bethea, T. T., Young, M., Valentino, R. J., & Lucki, I. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.183 · Cited by 124
Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development
Aldrich, J. V., & McLaughlin, J. P. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9105-4 · Cited by 124
Mutant mouse models of depression: Candidate genes and current mouse lines
Urani, A., Chourbaji, S., & Gass, P. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.020 · Cited by 128
Wee, S., Orío, L., Ghirmai, S., Cashman, J. R., & Koob, G. F. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1563-y · Cited by 119
Clark, M. S., Sexton, T. J., McClain, M. E., Root, D., Kohen, R., & Neumaier, J. F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04550.2002 · Cited by 119
Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder
Kang, H. J., Adams, D. H., Simen, A. A., Simen, B. B., Rajkowska, G., Stockmeier, C. A., Overholser, J. C., Meltzer, H. Y., Jurjus, G., Konick, L. C., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4083-07.2007 · Cited by 119
Vocalizations during withdrawal from opiates and cocaine: possible expressions of affective distress
Covington, H. E., & Miczek, K. A. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01558-9 · Cited by 121
Schindler, A. G., Messinger, D. I., Smith, J. S., Shankar, H., Gustin, R. M., Schattauer, S. S., Lemos, J. C., Chavkin, N. W., Hagan, C. E., Neumaier, J. F., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3220-12.2012 · Cited by 122
Wnt2 Expression and Signaling Is Increased by Different Classes of Antidepressant Treatments
Okamoto, H., Voleti, B., Banasr, M., Sarhan, M., Đurić, V., Girgenti, M. J., Dileone, R., Newton, S. S., & Duman, R. S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.023 · Cited by 116
The Nucleus Accumbens: A Common Target in the Comorbidity of Depression and Addiction
Xu, L., Nan, J., & Lan, Y. (2020) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.00037 · Cited by 123
Bockstaele, E. J. V., Reyes, B. A. S., & Valentino, R. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.036 · Cited by 115
Hebb, A. L. O., Zacharko, R. M., Gauthier, M. S., Trudel, F., Laforest, S., & Drolet, G. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03704.x · Cited by 113
Tejeda, H. A., & Bonci, A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.09.023 · Cited by 117
Elevated Expression of 5-HT1BReceptors in Nucleus Accumbens Efferents Sensitizes Animals to Cocaine
Neumaier, J. F., Vincow, E. S., Arvanitogiannis, A., Wise, R. A., & Carlezon, W. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10856.2002 · Cited by 114
Self-citationCarlezon, W. A., & Konradi, C. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.021 · Cited by 108
Self-citationPandey, S. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.002 · Cited by 109
Role of the Brain's Reward Circuitry in Depression
Nestler, E. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.07.003 · Cited by 108
Self-citationPsychobiological Mechanisms of Resilience and Vulnerability
Charney, D. S. (2004) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.2.3.368 · Cited by 127
Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A
Cunningham, C. W., Rothman, R. B., & Prisinzano, T. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003244 · Cited by 112
Wells, A. M., Ridener, E., Bourbonais, C. A., Kim, W., Pantazopoulos, H., Carroll, F. I., Kim, K., Cohen, B. M., & Carlezon, W. A. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0885-17.2017 · Cited by 110
Self-citationDoes the kappa opioid receptor system contribute to pain aversion?
Cahill, C. M., Taylor, A. M. W., Cook, C., Ong, E., Morón, J. A., & Evans, C. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00253 · Cited by 105
Psychostimulant withdrawal as an inducing condition in animal models of depression
Barr, A. M., & Markou, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.012 · Cited by 112
Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence
Walker, B. M., Valdez, G. R., McLaughlin, J. P., & Bakalkin, G. Y. (2012) · Alcohol · doi:10.1016/j.alcohol.2011.10.006 · Cited by 107
Molecular profiling of midbrain dopamine regions in cocaine overdose victims
Tang, W., Fasulo, W. H., Mash, D. C., & Hemby, S. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01740.x · Cited by 106
Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression
Iga, J.-I., Ueno, S.-I., Yamauchi, K., Numata, S., Kinouchi, S., Tayoshi-Shibuya, S., Song, H., & Ohmori, T. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.014 · Cited by 105
Muschamp, J. W., Veer, A. V., Parsegian, A., Gallo, M. S., Chen, M., Neve, R. L., Meloni, E. G., & Carlezon, W. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5973-10.2011 · Cited by 106
Self-citationKreibich, A., Reyes, B. A. S., Curtis, A. L., Ecke, L. E., Chavkin, C., Bockstaele, E. J. V., & Valentino, R. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0390-08.2008 · Cited by 104
Iñiguez, S. D., Vialou, V., Warren, B. L., Cao, J.-L., Alcantara, L. F., Davis, L. C., Manojlovic, Z., Neve, R. L., Russo, S. J., Han, M.-H., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0951-10.2010 · Cited by 103
Self-citationRussell, S. E., Rachlin, A. B., Smith, K. L., Muschamp, J. W., Berry, L., Zhao, Z., & Chartoff, E. H. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.042 · Cited by 103
Kappa opioid antagonists: Past successes and future prospects
Metcalf, M. D., & Coop, A. (2005) · The AAPS Journal · doi:10.1208/aapsj070371 · Cited by 103
Abildgaard, A. M., Solskov, L., Volke, V., Harvey, B. H., Lund, S. A., & Wegener, G. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.004 · Cited by 104
Faster, better, stronger: Towards new antidepressant therapeutic strategies
O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.046 · Cited by 104
The opioid system in depression
Jelen, L. A., Stone, J. M., Young, A. H., & Mehta, M. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104800 · Cited by 108
Gur, T., Conti, A. C., Holden, J., Bechtholt, A. J., Hill, T. E., Lucki, I., Malberg, J. E., & Blendy, J. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2051-07.2007 · Cited by 101
DiNieri, J. A., Nemeth, C. L., Parsegian, A., Carle, T. L., Gurevich, V. V., Gurevich, E. V., Neve, R. L., Nestler, E. J., & Carlezon, W. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5104-08.2009 · Cited by 98
Self-citationTargeting opioid dysregulation in depression for the development of novel therapeutics
Browne, C. A., & Lucki, I. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.009 · Cited by 100
Active behaviours produced by antidepressants and opioids in the mouse tail suspension test
Berrocoso, E., Ikeda, K., Sora, I., Uhl, G. R., Sánchez‐Blázquez, P., & Micó, J. A. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001842 · Cited by 95
Epigenetic Regulation in Substance Use Disorders
McQuown, S. C., & Wood, M. A. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0099-5 · Cited by 95
Licata, S. C., & Pierce, R. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01662.x · Cited by 93
Regulation of CRE‐mediated transcription in mouse brain by amphetamine
Shaw‐Lutchman, T. Z., Impey, S., Storm, D. R., & Nestler, E. J. (2003) · Synapse · doi:10.1002/syn.10172 · Cited by 92
Self-citationEndogenous κ Opioid Activation Mediates Stress-Induced Deficits in Learning and Memory
Carey, A. N., Lyons, A. M., Shay, C. F., Dunton, O., & McLaughlin, J. P. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6146-08.2009 · Cited by 91
Neural plasticity: consequences of stress and actions of antidepressant treatment
Duman, R. S. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.2/rduman · Cited by 95
Pilar-Cuéllar, F., Vidal, R., Díaz, Á., Castro, E., Dos-Anjos, S., Pascual-Brazo, J., Linge, R., Vargas, V. I., Blanco, H., Martínez‐Villayandre, B., et al. (2013) · Neural Plasticity · doi:10.1155/2013/537265 · Cited by 90
Potter, D. N., Damez-Werno, D. M., Carlezon, W. A., Cohen, B. M., & Chartoff, E. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.021 · Cited by 88
Self-citationThe Kappa-Opioid Agonist U69,593 Blocks Cocaine-Induced Enhancement of Brain Stimulation Reward
Tomasiewicz, H. C., Todtenkopf, M. S., Chartoff, E. H., Cohen, B. M., & Carlezon, W. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.029 · Cited by 90
Self-citationStress-Induced Potentiation of Cocaine Reward: A Role for CRFR1 and CREB
Kreibich, A. S., Briand, L., Cleck, J. N., Ecke, L., Rice, K. C., & Blendy, J. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.91 · Cited by 89
Green, T. A., Alibhai, I. N., Unterberg, S., Neve, R. L., Ghose, S., Tamminga, C. A., & Nestler, E. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5273-07.2008 · Cited by 89
Self-citationDopamine and opioid systems interact within the nucleus accumbens to maintain monogamous pair bonds
Resendez, S. L., Keyes, P. C., Day, J. J., Hambro, C., Austin, C. J., Maina, F. K., Eidson, L. N., Porter-Stransky, K. A., Nevárez, N., McLean, J. W., et al. (2016) · eLife · doi:10.7554/elife.15325 · Cited by 88
Leitl, M. D., Onvani, S., Bowers, M. S., Cheng, K., Rice, K. C., Carlezon, W. A., Banks, M. L., & Negus, S. S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.236 · Cited by 87
Self-citationSun, H., Green, T. A., Theobald, D. E. H., Birnbaum, S. G., Graham, D. L., Zeeb, F. D., Nestler, E. J., & Winstanley, C. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.030 · Cited by 87
Self-citationSchindler, A. G., Li, S., & Chavkin, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.67 · Cited by 85
Negus, S. S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1878-7 · Cited by 83
Zhang, H., Shi, Y., Woods, J. H., Watson, S. J., & Ko, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.045 · Cited by 85
Chartoff, E. H., Mague, S. D., Barhight, M. F., Smith, A. M., & Carlezon, W. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0491-06.2006 · Cited by 85
Self-citationMague, S. D., Andersen, S. L., & Carlezon, W. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.037 · Cited by 84
Self-citationAnimal models and treatments for addiction and depression co-morbidity
Paterson, N. E., & Markou, A. (2007) · Neurotoxicity Research · doi:10.1007/bf03033479 · Cited by 85
Tang, W., Wesley, M. J., Freeman, W. M., Liang, B., & Hemby, S. E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02392.x · Cited by 84
Karasinska, J. M., George, S. R., Cheng, R., & O’Dowd, B. F. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04353.x · Cited by 83
Levine, J. B., Youngs, R. M., MacDonald, M. L., Chu, M. S., Leeder, A., Francois Berthiaume, B., & Konradi, C. L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.063 · Cited by 81
Self-citationSex-related differential response to clomipramine treatment in a rat model of depression
Kokras, N., Antoniou, K., Dalla, C., Bekris, S., Xagoraris, M., Ovestreet, D., & Papadopoulou‐Daifoti, Z. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108095914 · Cited by 80
The role of signaling molecules in reward-related incentive learning
Beninger, R. J., & Gerdjikov, T. V. (2004) · Neurotoxicity Research · doi:10.1007/bf03033301 · Cited by 79
Desipramine Reduces Stress-Activated Dynorphin Expression and CREB Phosphorylation in NAc Tissue
Chartoff, E. H., Papadopoulou, M., MacDonald, M. L., Parsegian, A., Potter, D. N., Konradi, C. L., & Carlezon, W. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051417 · Cited by 80
Self-citationA role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress
Razzoli, M., Domenici, E., Carboni, L., Rantamäki, T., Lindholm, J., Ċastrén, E., & Arban, R. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00681.x · Cited by 80
Use patterns and self-reported effects of Salvia divinorum: An internet-based survey
Baggott, M. J., Erowid, E., Erowid, F., Galloway, G. P., & Mendelson, J. E. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.05.003 · Cited by 77
Chen, Y.-W., Rada, P. V., Bützler, B. P., LEIBOWITZ, S. F., & Hoebel, B. G. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.009 · Cited by 78
κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake
Whitfield, T. W., Schlosburg, J. E., Wee, S., Gould, A., George, O., Grant, Y., Zamora-Martinez, E. R., Edwards, S., Crawford, E., Vendruscolo, L. F., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1978-13.2015 · Cited by 75
The role of kappa opioid receptors in stress‐induced reinstatement of alcohol seeking in rats
Funk, D. R., Coen, K. M., & Lê, A. D. (2014) · Brain and Behavior · doi:10.1002/brb3.222 · Cited by 77
Antidepressant-like effects of cytidine in the forced swim test in rats
Carlezon, W. A., Pliakas, A. M., Parow, A. M., Detke, M. J., Cohen, B. M., & Renshaw, P. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01344-0 · Cited by 77
Self-citationBolaños, C. A., Wiley, M. D., Maffeo, M. L., Powers, K. D., Kinka, D. W., Grausam, K. B., & Henderson, R. P. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.024 · Cited by 75
Inducible cAMP Early Repressor (ICER) and Brain Functions
Borlikova, G. G., & Endo, S. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8072-1 · Cited by 72
Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H
Logrip, M. L., Janak, P. H., & Dorit Ron, A. (2009) · Alcohol · doi:10.1016/j.alcohol.2009.05.001 · Cited by 72
Spielewoy, C., & Markou, A. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300124 · Cited by 73
Salvinorin A Analogs and Other Kappa-Opioid Receptor Compounds as Treatments for Cocaine Abuse
Kivell, B. M., Ewald, A. W. M., & Prisinzano, T. E. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00012-3 · Cited by 71
Roles of Nucleus Accumbens CREB and Dynorphin in Dysregulation of MotivationPreprint
Muschamp, J. W., & Carlezon, W. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012005 · Cited by 74
Self-citationKappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders
Jacobson, M. L., Browne, C. A., & Lucki, I. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023317 · Cited by 70
Wang, C., Guo, J., & Guo, R. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1543-9 · Cited by 73
DBS of nucleus accumbens on heroin seeking behaviors in self-administering rats
Guo, L., Zhou, H., Wang, R., Xu, J., Zhou, W., Zhang, F., Tang, S., Liu, H., & Jiang, J. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.09.012 · Cited by 68
Bjørnebekk, A., Mathé, A. A., & Brené, S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300820 · Cited by 69
CREB Binding and Activity in Brain: Regional Specificity and Induction by Electroconvulsive Seizure
Tanis, K. Q., Duman, R. S., & Newton, S. S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.08.003 · Cited by 70
Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats
Der‐Avakian, A., D’Souza, M. S., Potter, D. N., Chartoff, E. H., Carlezon, W. A., Pizzagalli, D. A., & Markou, A. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4584-y · Cited by 69
Self-citationLoweth, J. A., Singer, B. F., Baker, L. K., Wilke, G. A., Inamine, H., Bubula, N., Alexander, J. K., Carlezon, W. A., Neve, R. L., & Vezina, P. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4383-09.2010 · Cited by 66
Self-citationThe cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders
Xiao, X., Zhang, C., Grigoroiu‐Serbânescu, M., Wang, L., Li, L., Zhou, D., Yuan, T.-F., Wang, C., Chang, H., Wu, Y. F., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.243 · Cited by 65
Donahue, R. J., Landino, S. M., Golden, S. A., Carroll, F. I., Russo, S. J., & Carlezon, W. A. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000155 · Cited by 67
Self-citationCrofton, E. J., Nenov, M. N., Zhang, Y., Scala, F., Page, S. A., McCue, D. L., Li, D., Hommel, J. D., Laezza, F., & Green, T. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.020 · Cited by 64
Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system
SIROHI, S. K., Bakalkin, G. Y., & Walker, B. M. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00095 · Cited by 68
Green, T. A., Alibhai, I. N., Hommel, J. D., Dileone, R., Kumar, A., Theobald, D. E. H., Neve, R. L., & Nestler, E. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0880-06.2006 · Cited by 63
Self-citationIntracellular signaling pathways pave roads to recovery for mood disorders
Tanis, K. Q., & Duman, R. S. (2007) · Annals of Medicine · doi:10.1080/07853890701483270 · Cited by 64
Bolaños, C. A., Perrotti, L. I., Edwards, S., Eisch, A. J., Barrot, M., Olson, V. G., Russell, D. S., Neve, R. L., & Nestler, E. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07569.2003 · Cited by 62
Hemby, S. E., Tang, W., Muly, E. C., Kuhar, M. J., Howell, L. L., & Mash, D. C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03517.x · Cited by 67
Paton, K. F., Atigari, D. V., Kaska, S., Prisinzano, T. E., & Kivell, B. M. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000134 · Cited by 61
Garza, R. D. L., & Asnis, G. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02757-4 · Cited by 64
Anderson, E. M., Larson, E. B., Guzman, D. D., Wissman, A. M., Neve, R. L., Nestler, E. J., & Self, D. W. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1657-17.2017 · Cited by 59
Self-citationBarot, S. K., Ferguson, S. M., & Neumaier, J. F. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05568.x · Cited by 59
Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression
Romeas, T., Morissette, M.-C., Mnie‐Filali, O., Piñeyro, G., & Boye, S. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1539-y · Cited by 59
Warren, B. L., Sial, O. K., Parise, L. F., Greenwood, M. A., Brewer, J. S., Rozofsky, J. P., Parise, E. M., & Bolaños‐Guzmán, C. A. (2014) · Developmental Neuroscience · doi:10.1159/000362875 · Cited by 64
Metadata
- Authors
- Pliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., & Carlezon, W. A.
- Affiliations
- Harvard University (US)
- The University of Texas Southwestern Medical Center (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2001-09-15
- Volume
- 21
- Issue
- 18
- Pages
- 7397-7403
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC4205577
- OpenAlex
- W1928329059
- Cited by
- 509
- References
- 42
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 8 · 2023: 9 · 2022: 4 · 2021: 9 · 2020: 12 · 2019: 13 · 2018: 12 · 2017: 20 · 2016: 21 · 2015: 22 · 2014: 23 · 2013: 28 · 2012: 33
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institute of Mental Health
- National Institute on Drug Abuse (R01DA007134)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- CREB, nucleus accumbens, cocaine reward, cocaine withdrawal, depression-like behavior, kappa opioid receptor, nor-binaltorphimine, dynorphin, dominant-negative CREB, place conditioning
- MeSH terms
- Animals, Cocaine, Conditioning, Psychological, Dynorphins, Genes, Dominant, Genetic Vectors, Male, Microinjections, Motor Activity, Narcotic Antagonists, Nucleus Accumbens, Reaction Time, Swimming, Gene Expression, Rats, Sprague-Dawley, Cyclic AMP Response Element-Binding Protein, Receptors, Opioid, kappa, Gene Transfer Techniques, Simplexvirus, Hypokinesia, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review